Investigation was carried out to determine the influence of short term administration of recombinant bovine somatotropin (rBST) on plasma growth hormone (GH), Insulin like growth factor-I (IGF-I), prolactin (PRL) and milk production of buffaloes in early lactation. Experimental buffaloes received i.v. rBST infusion in jugular vein @ 5mg/hr. i.v. for 5 days, while control group was given placebo injection. Blood samples were collected for 5 consecutive days before, during and after treatment and plasma GH, IGF-I and PRL levels were measured. Administration of rBST increased plasma GH (P<0.01) and IGF-I (P<0.01) concentration simulating to increased milk yield (P<0.01). Milk IGF-I concentration was more after cessation of treatment (P<0.05) than before and during the treatment period. The milk yield increased by 29.9% during the experiment (P<0.01) in comparison to control. rBST treatment influenced milk protein (P<0.01) and lactose (P<0.01) without affecting plasma glucose and NEFA, milk NEFA, citric acid and fat content. There was no adverse effect of rBST on mammary health and plasma prolactin concentration. The positive correlation of GH and IGF-I with milk yield indicated a galactopoietic effect of both the hormones to augment milk production in buffaloes.
INTRODUCTION
Buffalo is the major source of milk production and contributes more than 54 % of annual milk production in India (Hegde, 2006) . Bovine somatotropin is a homeiorhetic agent affecting hepatic and adipose tissue (Etherton and Bauman, 1998) . Administration of rBST increase milk yield in cows, buffaloes and goats (Ludrt et al., 1989; Etherton and Bauman, 1998; Radchiff et. al., 2000; Helal and Lasheen, 2008) . The effect of rBST on milk composition and mastitis incidence are well established (Bauman, 1992; Chalupa et al., 1996) . However, effect of intravenous rBST administration on hormones (GH, insulin like growth factor-I, prolactin) in relation to milk production and composition in early lactation has not been reported in buffaloes.
MATERIAL AND METHODS
Experimental Animals and treatment: Ten Murrah buffaloes in early lactation (16 days) were selected from Institute's buffalo herd and were managed in a loose housing system with brick floor. These were offered ad lib green fodder-berseem (Trifolium alexandrium) while concentrate mixture (70 % TDN and 21 % CP) was offered based on milk production. Drinking water was available ad lib. to all buffaloes.
Hand milking of buffaloes was carried twice a day in morning and evening and milk yields were recorded. The experimental buffaloes were infused intravenously solution of recombinant bovine somatotropin (rBST, Monsanto; NHPP-NIDDK, Lot-M010-001), @ 5mg/ animal /day for 5 consecutive days (day 21 to 25 postpartum) in jugular vein through a catheter. The control group buffaloes were given placebo injections.
Collection of Samples and analysis: Jugular blood samples were collected in heparinized tubes at 8:00 A.M daily for 5 consecutive days before (-5, -4, -3, -2 -1 day), during (1, 2, 3, 4, 5 day) and after (+1, +2, +3, +4, +5 day) intravenous infusion of rBST. Milk samples collected at intervals of blood sampling, were analyzed for fat (REMI), protein (Singhal and Desraj, 1989) , lactose (Perry and Doon, 1950) , nonesterified fatty acids, NEFA (Shipe et al. 1980 ) and milk IGF-I ( Malven et al. 1987 ) . Blood glucose was estimated by the Kit (25940, Span Diagnostics Ltd. GOD/POD). Plasma GH, IGF-I and prolactin were measured by double antibody radioimmunoassay procedures (Singh and Ludri, 2000) . Statistical analysis of data was carried out using Least Square Analysis (3-way ANOVA) with interaction (Snedecor and Cochran, 1980) .
RESULTS
Mean GH and IGF-I levels varied (P<0.01) between days and between group (P<0.01). However, between animal variation for GH and IGF-I level was non-significant except prolactin which varied (P<0.05). Plasma GH and IGF-I was higher (P<0.01) in experimental than in control group during and after treatment (Figure 1 ). Milk yield increased during (29.9%) and after treatment (19.4%) concomitant to rise in plasma GH and IGF-I level. Higher plasma GH and IGF-I levels were observed during the posttreatment period in comparison to control. Milk IGF-I levels was 34.67±3.48 ng/ml (29.68±4.54 to 38.10±3.35 ng/ml) before treatment. The IGF-I levels were low during treatment on day 1, 2, 3 but was higher on day 4 and 5 of treatment and continued ( Figure 4 ). However, milk IGF-I level was high (42.02±5.22 ng/ml) on day 1 post treatment and declined thereafter. When the data was pooled for three phases of treatment, overall average milk IGF-I levels was non-significantly different.
Fat content of milk of both the group was similar before treatment (6.88±0.16 vs. 6.99±0.21%) and increased non-significantly during the treatment (7.04±0.41 to 7.27±0.31). The protein content of milk varied (P<0.01) between groups, but between animal and between period variation was non-significant. Lactose varied between groups (P<0.01) and between periods of the study (P<0.01). Milk NEFA concentration non-significantly varied between groups, between animals and between periods of the study. Citric acid content of milk varied between the groups (P<0.05) and was low in experimental buffaloes in comparison to control.
Plasma IGF-I level was positively correlated with plasma glucose, lactose (P<0.05), milk yield and protein (P<0.01). Milk yield, glucose (P<-0.01) and fat (P<0.05) varied between animal. rBST treatment increased protein and lactose content (P<0.01) without any adverse effect on plasma glucose, NEFA, milk NEFA, and fat. Milk yield, protein, lactose (P<0.01) and citric acid (P<0.05) varied between the groups. The variation in milk yield, plasma glucose (P<0.01) and fat between animal was significant (P<0.05). Milk yield was positively correlated to lactose (P<0.05), GH and IGF-I (P<0.01). Fat was positively correlated with milk NEFA (P<0.05), while milk NEFA was correlated positively with citric acid (P<0.01). Lactose was positively correlated to GH (P<0.01) and IGF-I (P<0.05). 
DISCUSSION
The significant increase in milk production of experimental buffaloes concomitant to elevated GH and IGF-I levels suggests role of both the hormones in milk secretion of buffaloes in early lactation (Singh and Ludri, 1994) . However, varied response of treatment in different buffaloes was attributed to circulating plasma GH levels in buffaloes (Singh and Ludri, 1994) and cows (Erdman et al., 1999; Chalupa et al., 1996) . The significantly higher IGF-I in rBST treated buffaloes on different days, during and after treatment period corroborates that GH act via IGF-I (Winder and Forsyth, 1986; Prosser et al., 1987; Faulkner, 1999) . Further, the lag period of IGFI secretion in milk was 3 days and the milk IGF-I levels were still higher as observed by Faulkner (1999) in goats. Conversely cow milk IGF-I concentrations were significantly increased (P<0.05) in comparison to plasma and milk GH concentration for early, mid and late lactation periods (Zhao, et al., 1994) . .Administration of rBST in doses of 25 and 50 mg/day i.m. for 14 days increase milk production without affecting fat and protein (Ludri et al., 1989) contrary to increased fat, protein and lactose observed in this study. The reasons of such short term treatment on milk composition of buffaloes require further investigation as milk composition is influenced by energy balance and mobilization of body reserves (Eppard et al., 1985; Peel et al., 1982 and Tyrrell et. al. 1988) . Prolactin concentration was not affected by rBST as it has no role in established lactation (Saha and Singh, 1998) . CONCLUSION Intravenous administration of rBST increased milk production by increasing plasma GH and IGF-I (P<0.01) without change in prolactin level. The effect of rBST was long term and persists five days post-treatment due to higher GH and IGF-I level and lead to higher milk IGF-I concentration. The rBST treatment increase milk protein (P<0.01) and lactose (P<0.01), while plasma glucose and NEFA, milk NEFA, fat and prolactin remain unaffected.
